Results 31 to 40 of about 192,096 (187)
Eluforsen (previously known as QR-010) is a 33-mer 2′-O-methyl modified phosphorothioate antisense oligonucleotide targeting the F508del mutation in the gene encoding CFTR protein of cystic fibrosis patients.
Jaeah Kim +6 more
doaj +1 more source
Challenges and future perspective of antisense therapy for spinal muscular atrophy: A review
Spinal muscular atrophy (SMA), the most common genetic cause of infantile death, is caused by a mutation in the survival of motor neuron 1 gene (SMN1), leading to the death of motor neurons and progressive muscle weakness.
Zorica Nakevska, Toshifumi Yokota
doaj +1 more source
Primers used for RT-PCR. S, sense oligonucleotide; AS, antisense oligonucleotide.
Primers used for RT-PCR. S, sense oligonucleotide; AS, antisense oligonucleotide.
Andrea-Kaye Datu (584123) +1 more
core +1 more source
Evidence for a Specific Intracellular Localization of an Antisense Oligonucleotide in K562 Cells
In order to be active, antisense oligonucleotides (ASOs) should be delivered to the nuclei of cells. The lack of effect of some ASOs might be explained by poor distribution inside the cell.
M. Helena Vasconcelos +4 more
doaj +1 more source
Oligonucleotide Mimics for Antisense Therapeutics: Solution Phase and Automated Solid-Support Synthesis of MMI Linked ...
Michel Perbost (2995368) +4 more
core +2 more sources
Polymerase-endonuclease amplification reaction for large-scale enzymatic production of antisense oligonucleotide [PDF]
Synthetic oligonucleotides are contaminated with highly homologous failure sequences. Oligonucleotide synthesis is difficult to scale up because it requires expensive equipments, hazardous chemicals, and tedious purification process.
Deming Gou, Xiaolong Wang
core
Silencing disease genes in the laboratory and the clinic
Synthetic nucleic acids are commonly used laboratory tools for modulating gene expression and have the potential to be widely used in the clinic. Progress towards nucleic acid drugs, however, has been slow and many challenges remain to be overcome before
Jonathan K Watts +3 more
core +1 more source
WO 2014203008 A1 Antisense oligonucleotide compositions
The present invention relates to antisense oligonucleotide (ASO) compositions and particularly to compositions and methods for the cytosolic delivery of antisense oligonucleotides (ASOs).
Mitchell, John +2 more
core +5 more sources
Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis
Antisense oligonucleotides, which are used to silence target genes, are gaining attention as a novel drug discovery modality for proteinopathies. However, while clinical trials for neurodegenerative diseases like amyotrophic lateral sclerosis have been ...
Daisuke Ito, Kensuke Okada
doaj +1 more source
الملخص: أهداف البحث: تزداد معدلات الإصابة بسرطان اللسان، المعروف بطبيعته العدوانية، سنويًّا في إندونيسيا وعلى مستوى العالم. ويرتبط أحد العوامل الجزيئية المرتبطة بسرطان اللسان البشري بارتفاع التعبير عن الحمض النووي الريبوزي الطويل غير المشفِّر (LINC٠٠٦٧٣)
Kadek Gede Putra Wibawa, DDS +2 more
doaj +1 more source

